Publications


Publications
Repositioning « old » drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion.

Clinical & experimental metastasis

Shah ET, Upadhyaya A, Philp LK, Tang T, Skalamera D, Gunter J, Nelson CC, Williams ED, Hollier BG
Clinical & experimental metastasis - vol. 33 385-399 (2016)

The majority of prostate cancer (PCa) deaths occur due to the metastatic spread of tumor cells to distant organs. Currently, there is a lack of effective therapies once tumor cells have spread outside the prostate. It is therefore imperative to rapidly develop therapeutics to inhibit the metastatic spread of tumor cells. Gain of cell motility […]

Publications
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine ␤ -synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon

Pharmacological Research

Druzhyna N, Szczesny B, Olah G, Módis K, Asimakopoulou A, Pavlidou A, Szoleczky P, Gerö D, Yanagi K, Törö G, López-garcía I, Myrianthopoulos V, Mikros E, Zatarain JR, Chao C, Papapetropoulos A, Hellmich MR, Szabo C
Pharmacological Research - vol. 113 18-37 (2016)

Publications
Novel cell-based in vitro screen to identify small-molecule inhibitors against intracellular replication of Cryptococcus neoformans in macrophages.

International journal of antimicrobial agents

Samantaray S, Correia JN, Garelnabi M, Voelz K, May RC, Hall RA
International journal of antimicrobial agents - vol. 48 69-77 (2016)

The fungal pathogen Cryptococcus neoformans poses a major threat to immunocompromised patients and is a leading killer of human immunodeficiency virus (HIV)-infected patients worldwide. Cryptococci are known to manipulate host macrophages and can either remain latent or proliferate intracellularly within the host phagocyte, a favourable niche that also renders them relatively insensitive to antifungal agents. […]

Publications
Benzbromarone, Quercetin, and Folic Acid Inhibit Amylin Aggregation.

International journal of molecular sciences

López LC, Varea O, Navarro S, Carrodeguas JA, Sanchez de Groot N, Ventura S, Sancho J
International journal of molecular sciences - vol. 17 (2016)

Human Amylin, or islet amyloid polypeptide (hIAPP), is a small hormone secreted by pancreatic β-cells that forms aggregates under insulin deficiency metabolic conditions, and it constitutes a pathological hallmark of type II diabetes mellitus. In type II diabetes patients, amylin is abnormally increased, self-assembled into amyloid aggregates, and ultimately contributes to the apoptotic death of […]

Publications
Characterization and application of two RANK-specific antibodies with different biological activities

Immunology Letters

Chypre M, Seaman J, Cordeiro OG, Willen L, Knoop KA, Buchanan A, Sainson RCA, Williams IR, Yagita H, Schneider P, Mueller CG
Immunology Letters - vol. 171 5-14 (2016)

Antibodies play an important role in therapy and investigative biomedical research. The TNF-family member Receptor Activator of NF-??B (RANK) is known for its role in bone homeostasis and is increasingly recognized as a central player in immune regulation and epithelial cell activation. However, the study of RANK biology has been hampered by missing or insufficient […]

Publications
Development of a Multiplex Assay for Studying Functional Selectivity of Human Serotonin 5-HT2A Receptors and Identification of Active Compounds by High-Throughput Screening.

Journal of biomolecular screening

Iglesias A, Lage S, Cadavid MI, Loza MI, Brea J
Journal of biomolecular screening (2016)

G protein-coupled receptors (GPCRs) exist as collections of conformations in equilibrium, and the efficacy of drugs has been proposed to be associated with their absolute and relative affinities for these different conformations. The serotonin 2A(5-HT2A) receptor regulates multiple physiological functions, is involved in the pathophysiology of schizophrenia, and serves as an important target of atypical […]

Publications
Deriving human ENS lineages for cell therapy and drug discovery in Hirschsprung disease.

Nature

Fattahi F, Steinbeck JA, Kriks S, Tchieu J, Zimmer B, Kishinevsky S, Zeltner N, Mica Y, El-Nachef W, Zhao H, de Stanchina E, Gershon MD, Grikscheit TC, Chen S, Studer L
Nature - vol. 531 105-9 (2016)

The enteric nervous system (ENS) is the largest component of the autonomic nervous system, with neuron numbers surpassing those present in the spinal cord. The ENS has been called the ‘second brain’ given its autonomy, remarkable neurotransmitter diversity and complex cytoarchitecture. Defects in ENS development are responsible for many human disorders including Hirschsprung disease (HSCR). […]

Publications
Identifying ligands at orphan GPCRs : current status using structure-based approaches Tables of Links

British Journal of Pharmacology

Ngo T, Kufareva I, Coleman JLJ, Graham RM, Abagyan R, Smith NJ
British Journal of Pharmacology - vol. 173 2934-2951 (2016)

Publications
Recycler un anti-hypertenseur pour combattre les tumeurs du cerveau

Communiqué de presse national

Chneiweiss H, Junier M, Etienne V
Communiqué de presse national (2016)

Publications
Cancer stem cell quiescence and plasticity as major challenges in cancer therapy

Stem Cells International

Chen W, Dong J, Haiech J, Kilhoffer MC, Zeniou M
Stem Cells International - vol. 2016 (2016)

Cells with stem-like properties, tumorigenic potential, and treatment-resistant phenotypes have been identified in many human malignancies. Based on the properties they share with nonneoplastic stem cells or their ability to initiate and propagate tumors in vivo, such cells were designated as cancer stem (stem-like) or tumor initiating/propagating cells. Owing to their implication in treatment resistance, […]